GSK adds jobs at North Carolina plant, expecting new drugs to take off – FiercePharma Manufacturing
0
While GlaxoSmithKline’s new drugs Anoro and Breo have yet to take flight like the company had hoped, the drugmaker ($GSK) has been expanding the North Carolina plant where it makes them and other respiratory drugs, expecting that they will.
The U.K. company has invested about $90 million in the plant in Zebulon, where those drugs and two other more recently approved respiratory meds, Incruse and Arnuity, are made, along with the Ellipta inhaler that dispenses them, the Triangle Business Journal reports. Those dollars have covered everything from plant expansion to equipment and some raw materials.
Read more – FiercePharma Manufacturing